Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Graham G Russell

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Biorxiv : the Preprint Server for Biology|March 3, 2023
<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markersParinya Samakkarnthai, Dominik Saul, Lei Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against SenescenceJinsen Lu, Srinivasa Rao Rao, Helen Knowles, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Biorxiv : the Preprint Server for Biology|March 3, 2023
<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markersParinya Samakkarnthai, Dominik Saul, Lei Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against SenescenceJinsen Lu, Srinivasa Rao Rao, Helen Knowles, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
Pageof 7